Research Biomarkers For The Diagnosis Of Alzheimer’s Disease
Shreyashi M1, Sulagna D2, Swamynathan G3, Infant Santhose B4
1Shreyashi M, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu, India. 

2Sulagna D, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu, India. 
3Swamynathan G, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu, India.
4Infant Santhose B, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Tamilnadu, India.
Manuscript received on February 05, 2019. | Revised Manuscript received on February 14, 2019. | Manuscript published on August 30, 2019. | PP: 3633-3636 | Volume-8 Issue-6, August 2019. | Retrieval Number: F9363088619/19©BEIESP | DOI: 10.35940/ijeat.F9363.088619
Open Access | Ethics and Policies | Cite | Mendeley
© The Authors. Blue Eyes Intelligence Engineering and Sciences Publication (BEIESP). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Abstract: Alzheimer’s disease (AD) is a neuronal disease that is characterized by the loss of neurons and cognitive impairment. There is no definitive cure and current treatment options are focused more on reducing the damage caused by the disease and providing care for the patients. Early diagnosis of the disease will help in minimizing the damage and give better treatment options. In this review we try to analyze a few important risk factors and identify some biomarkers in blood and cerebrospinal fluid (CSF) which could be used for the diagnosis of AD
Keywords: focused, characterized, cerebrospinal.